WO2013131494A1 - 一种利用禽血生产低灰分禽血浆蛋白粉的方法 - Google Patents
一种利用禽血生产低灰分禽血浆蛋白粉的方法 Download PDFInfo
- Publication number
- WO2013131494A1 WO2013131494A1 PCT/CN2013/072366 CN2013072366W WO2013131494A1 WO 2013131494 A1 WO2013131494 A1 WO 2013131494A1 CN 2013072366 W CN2013072366 W CN 2013072366W WO 2013131494 A1 WO2013131494 A1 WO 2013131494A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plasma
- blood
- protein powder
- poultry
- avian
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/06—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/12—Animal proteins from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/24—Animal feeding-stuffs from material of animal origin from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
Definitions
- the present invention relates to the field of biotechnology and modern agriculture; in particular, to a method for preparing low ash avian blood plasma protein powder using poultry blood. Background technique
- Another object of the present invention is to provide a high protein content, low ash avian plasma protein powder and its use.
- a first aspect of the present invention provides a method for preparing a low ash avian blood plasma protein powder, the method comprising the steps of:
- step (f) adding an emulsifier to the ultrafiltration-treated plasma liquid obtained in the step (e), and performing an emulsification treatment to obtain emulsified plasma;
- the bird blood is derived from poultry or birds.
- the poultry is a chicken, duck, or goose; the bird is a pigeon or a sparrow.
- the anticoagulant component is sodium citrate, and the anticoagulant is added in an amount of 0.1 to 5% (w/w) of the total amount of whole blood.
- the amount of the anti-coagulant is 0. 4 ⁇ 2% (w / w), preferably 0. 5 ⁇ 1% (w / w); The best is 1% (w/w).
- the step (a) is to dispose the anticoagulant in an anticoagulant solution having a concentration of 8 to 15%, and mix the anticoagulant aqueous solution with the avian blood to obtain anticoagulated whole blood.
- the water used to dispose the anticoagulant is pure water or water filtered through a 200 molecular weight nanofiltration membrane (water permeable to the filtration membrane).
- the steps between steps (a) and (b) include the steps of: pre-filtering the anticoagulated whole blood to remove impurities such as hair, stones, etc., thereby obtaining pre-filtered anticoagulated whole blood.
- the centrifugation in the step (b) is carried out using a tube centrifuge; and/or the centrifugation in the step (d) is carried out using a disc centrifuge.
- the centrifugal treatment in the step (b) has a centrifugal speed of 6,000 to 16,000 rpm, preferably 11,000 rpm.
- the centrifugal treatment in the step (d) has a centrifugal speed of 8,000 to 15,000 rpm, preferably 11,000 rpm.
- step (b) further comprises the step of: cooling the separated plasma solution at a storage temperature of 2 to 10 ° C; preferably 4 ° C.
- the decalcifying agent comprises a water-soluble carbonate (such as sodium carbonate, potassium carbonate, ammonium carbonate, or a combination thereof); and/or 02 ⁇ 0. 5% ( w/w) (preferably 0 ⁇ 05 ⁇ 0 ⁇ 3), in the step (c), the amount of the decalcifying agent is 0. 02 ⁇ 0. 5% (w/w) % ( w / w) , more preferably 0 ⁇ 1% ( w / w ) ); and / or in the step (f), the emulsifier is added in the amount of the plasma liquid obtained in the step (e) 0. 01 ⁇ 0. 5 % (w/w) ;
- the emulsifier is selected from the group consisting of fatty acid monoglycerides, sorbitol lipids, soybean phospholipids, or combinations thereof; and/or
- the inlet air temperature is 220 ° C to 230 ° C
- the outlet air temperature is 80 ° C to 85 ° C.
- the time of the precipitation reaction is 0. 5 ⁇ 4 hours.
- the step (c) is to prepare sodium carbonate as an aqueous solution having a concentration of 20% by weight, and then slowly add it to the plasma liquid.
- the emulsifier is added in an amount of 0.01 to 0.1% (w/w) of the plasma solution obtained in the step (e); the emulsifier is sorbitol.
- the selected ultrafiltration membrane is an ultrafiltration membrane having a molecular weight of 300,000 to 500,000;
- step (g) sodium filtration is carried out using a nanofiltration membrane having a molecular weight of 200 to 1000, and the volume ratio of the plasma concentrated liquid to the filtered water is 1: 2 to 4, and the plasma concentrated liquid is collected.
- the ultrafiltration membrane in the step (e), is an ultrafiltration membrane having a molecular weight of more than 300,000. In another preferred embodiment, in the step (e), the ultrafiltration membrane is an ultrafiltration membrane having a molecular weight of 35 to 500,000. In another preferred embodiment, the ultrafiltration membrane is a 400,000 molecular weight filter membrane.
- the nanofiltration membrane is a 200-500 molecular weight nanofiltration membrane; preferably a 200 molecular weight nanofiltration membrane.
- the method further comprises the step of: mixing the dried plasma protein powder with a component selected from the group consisting of cereals, corn, soybeans, and whey to obtain a pelletized feed.
- a second aspect of the present invention provides an avian blood plasma protein powder, wherein the protein powder has a protein content of 70%, an immunoglobulin content of 14%, and an ash content of 15%.
- the protein content is 70 to 78%; the immunoglobulin content is 14 to 30%; and the ash content is 8 to 15%.
- the plasma protein powder is produced by the method of the first aspect of the invention.
- a third aspect of the invention provides the use of a protein powder according to the second aspect of the invention for the preparation of a feed composition or a food composition.
- Figure 1 shows a schematic flow chart of the preparation of plasma protein powder using avian blood. detailed description
- the inventors have unexpectedly discovered a method for preparing low-ash avian plasma protein powder by long-term and in-depth research, which removes fibrin by precipitation decalcification and ultrafiltration on the basis of anticoagulation, centrifugation and the like.
- the original and most of the grease and the emulsified residual oil effectively solve the defects such as the non-nanofiltration treatment of the poultry blood, which is very beneficial to the subsequent operation and significantly improves the efficiency of the entire preparation process.
- the plasma protein powder obtained by the method has the advantages of high protein content (especially immunoglobulin content), low ash content, good palatability, and amino acid balance, and is very suitable for use in feed and food. On this basis, the inventors completed the present invention. Definition
- avian is also commonly known as birds, including birds and poultry such as, but not limited to, chickens, ducks, geese, pigeons, sparrows, and the like. Poultry is preferred. Preparation
- the method for preparing (or processing) the avian blood plasma protein powder uses the poultry processing by-product poultry blood as a raw material, adopts technologies such as anti-coagulation, ultrafiltration, emulsification, nanofiltration and spray drying to obtain a high protein content, Low ash avian plasma protein powder.
- step (c) adding sodium carbonate to the plasma solution obtained in the step (b) to carry out a precipitation reaction to obtain a precipitated plasma reaction solution;
- step (f) adding an emulsifier to the ultrafiltration-treated plasma liquid obtained in the step (e), and performing an emulsification treatment to obtain emulsified plasma;
- the blood of the present invention is derived from poultry, including poultry and birds.
- poultry including poultry and birds.
- the blood components of birds are very similar, and thus any bird is included in the present invention.
- the blood derived from various poultry can be used as a raw material for the preparation method of the avian blood protein powder of the present invention.
- the birds include, but are not limited to: chickens, ducks, geese, pigeons, sparrows, and the like. Poultry is preferred.
- fresh and healthy avian blood is used as a raw material for the production of low ash plasma protein powder.
- the separation of plasma and blood cells from the blood can be carried out by techniques well known to those skilled in the art, for example, separation of anticoagulated whole blood to obtain a plasma solution and a blood cell solution, and then treating the plasma liquid as a raw material for producing a plasma protein powder.
- Avian blood anticoagulation for example, separation of anticoagulated whole blood to obtain a plasma solution and a blood cell solution, and then treating the plasma liquid as a raw material for producing a plasma protein powder.
- the anticoagulation treatment of the present invention may employ techniques well known to those skilled in the art.
- avian blood is mixed with an anticoagulant to obtain anticoagulated whole blood.
- the anticoagulant can be configured as an anti-coagulation aqueous solution of 8 to 15% by weight, and the anticoagulant aqueous solution is mixed with the avian blood to obtain anticoagulated whole blood; wherein the water for arranging the anticoagulant aqueous solution can be It is pure water, or water filtered through a 200 molecular weight nanofiltration membrane (water selected through the membrane).
- the amount of the anticoagulant added may be determined depending on the characteristics of the raw material of the poultry, such as the difficulty of anticoagulation. Preferably, it is 0.1 to 5% (w/w) of the total amount of whole blood; preferably 0.4 to 2% (w/w), more preferably 1% (w/w).
- the anticoagulation treatment can be carried out as follows:
- the anticoagulant and water are dissolved in an anti-coagulation aqueous solution according to a weight ratio of 8 to 15% (w/w), and the configured anti-coagulation aqueous solution is placed in a spray container, and the amount of the anti-condensation aqueous solution is 1 ⁇ 30% ( v / v ) (preferably 5 to 15% ( v / v ) ) or according to the amount of anticoagulant added to the total amount of whole blood 0. 1 ⁇ 5% (w / w), mixed with avian blood, Combined with stirring, the anti-coagulation aqueous solution is uniformly mixed with the avian blood. Centrifugal separation
- the anticoagulated whole blood obtained in the above step is preferably first subjected to pre-filtration treatment (such as filtration through a filter bag) to remove impurities such as hair and stones, and then centrifuged by a blood tube centrifuge ( If the rotation speed is 8000 - 15000 rpm, preferably 11,000 rpm, the obtained light liquid is the poultry plasma solution.
- pre-filtration treatment such as filtration through a filter bag
- the obtained light liquid is the poultry plasma solution.
- the anticoagulated poultry blood is subjected to pre-filtration treatment and immediately centrifuged.
- the separated plasma solution and blood cell solution are separately stored in a refrigeration state at a storage temperature of 1 - 10 ° C (preferably 4 ° C).
- Adding a decalcifying agent to the plasma solution obtained in the above step includes a water-soluble carbonate (such as sodium carbonate, potassium carbonate, ammonium carbonate, or a combination thereof), and the amount of the decalcifying agent added is the above-mentioned step to obtain a plasma liquid.
- a water-soluble carbonate such as sodium carbonate, potassium carbonate, ammonium carbonate, or a combination thereof
- the amount of the decalcifying agent added is the above-mentioned step to obtain a plasma liquid.
- 02 ⁇ 0. 5% (w/w) used to synthesize free calcium ions in plasma to form calcium carbonate precipitate, which is then removed by centrifugation.
- the avian plasma solution obtained in the above step is subjected to ultrafiltration treatment, and the ultrafiltration treatment may be carried out according to a conventional operation in the field, for example, ultrafiltration using a 30-500,000 molecular weight filtration membrane (preferably a 400,000 molecular weight filter membrane).
- the fibrinogen and most of the oil are removed, and the filtrate is collected to obtain an ultrafiltered plasma solution.
- the invention adopts modern biofilm technology, uses ultra-filtration of 30 ⁇ 500,000 molecular weight membranes to realize the removal of avian fibrinogen and some oils, and solves the problem of high viscosity of poultry blood and difficult nanofiltration treatment.
- Emulsification treatment uses ultra-filtration of 30 ⁇ 500,000 molecular weight membranes to realize the removal of avian fibrinogen and some oils, and solves the problem of high viscosity of poultry blood and difficult nanofiltration treatment.
- the operation step of the emulsification treatment is a conventional operation method, for example, adding an emulsifier to the plasma liquid obtained in the above step to emulsify the residual oil and fat, and the emulsifier may be selected from the group consisting of fatty acid monoglyceride, sorbitol fat, soybean The phospholipid is preferably a sorbitol fat.
- the amount of the emulsifier added can be determined according to the fat content of the plasma liquid. 01 ⁇ 0. 5 % (or 0. 05 ⁇ 0. 1%) (w/w). The amount of the emulsifier is 0. 01 ⁇ 0. 5 % (or 0. 05 ⁇ 0. 1%) (w/w). Plasma nanofiltration
- the emulsified plasma solution obtained in the above step is subjected to sodium filtration treatment, and the sodium filtration treatment may be carried out according to a conventional operation in the field, for example, the emulsified plasma solution is subjected to a membrane nanofiltration of 200-1000 molecular weight (preferably 200 molecular weight). Concentration, so that the volume ratio of concentrated plasma to filtered water is 1: 1 to 6 (preferably 1: 2 to 4 or 1: 3 to 4), and most of the water and salt in the plasma are removed to obtain a plasma concentrate.
- the invention concentrates by nanofiltration, increases the dry matter content of the poultry plasma liquid, and greatly reduces the plasma drying cost. Dry
- the plasma concentrate obtained above is dried.
- the drying may be carried out by a drying method commonly used by those skilled in the art, preferably spray drying, and the inlet air temperature may be 220 ° C to 230 ° C, and the outlet air temperature may be 80 ° C to 85 ° 85. °C.
- the method of the present invention will now be further illustrated in conjunction with FIG. 1 and a preferred embodiment:
- the anticoagulant and the water are placed in an 8 ⁇ 15% (w/w) ratio of the anticoagulant aqueous solution, and added to the collected poultry blood.
- the anticoagulant aqueous solution is added in an amount of 5 to 20% of the avian blood volume ( v/v), stirring, so that the anti-coagulation aqueous solution is evenly mixed with the avian blood to obtain anticoagulated (avian) whole blood.
- a sodium carbonate solution (e.g., a 20% by weight aqueous solution of sodium carbonate) is added to the plasma solution stored at a temperature of 4 ° C, and stirred for 0.5 to 4 hours to carry out a precipitation reaction.
- the plasma reaction solution subjected to the precipitation reaction is centrifuged in a disc centrifuge to remove the precipitate to obtain a decalcified plasma solution.
- the decalcified plasma solution is ultrafiltered using a 30-500,000 molecular weight filter membrane to remove fibrinogen and most of the oil and fat to obtain filtrate plasma.
- the emulsification is obtained by the emulsification of the effluent of the effluent of the effluent of the effluent of the effluent of the effluent of the effluent. plasma.
- the emulsified plasma is concentrated by nanofiltration with a molecular weight membrane of 200, and the concentration ratio is 1: 2 to 4 (ie, concentrated plasma: filtered water) (preferably 1: 3 to 4), and most of the water and salt are removed to obtain Concentrate the plasma.
- the poultry blood plasma protein powder provided by the invention has excellent indexes, and the protein content thereof is as high as 70% or more, wherein the functional component immunoglobulin (such as IgY) reaches 14%, the palatability is good, the amino acid balance, and the ash content is less than 15%. 5 % ⁇ The moisture content is less than 6%, the salt content is less than 2. 6 %.
- the functional component immunoglobulin such as IgY
- the avian blood plasma protein powder provided by the invention can be applied to the fields of feed and food.
- the dried plasma protein powder is mixed with a component selected from the group consisting of cereals, corn, soybeans, and whey to obtain a granular feed composition or food composition for feeding the weaned pups.
- the avian plasma protein powder provided by the invention greatly reduces the salt during the processing, retains the activity of various functional immunoglobulins in the original plasma, and can effectively prevent the intestinal infection of the rearing animal when used in the feed. Reduce immune stimuli and improve the nutritional metabolism and immunity of weaned pups. It can be applied to feed materials as a feed material and a nursery material; it can also be applied to food compositions.
- the main advantages of the invention are:
- the present invention provides a method for preparing low ash avian blood plasma protein powder.
- the method uses poultry blood as a raw material to produce avian blood plasma protein powder.
- the invention overcomes the defect that the avian blood is difficult to be deep-processed, thereby preparing a low-ash, high-protein content (especially immunoglobulin) plasma protein powder, and is the first to realize the poultry blood processing at home and abroad to prepare high-end nutritional quality avian blood plasma protein powder. .
- the method uses the precipitation reaction of the anti-condensed poultry plasma solution to remove calcium ions in the plasma; the defibrinogen and oil emulsification are carried out by ultrafiltration and emulsification to prevent blood agglomeration and plugging the filter membrane; , effectively reduce the ash content in plasma, increase the content of effective indicators such as plasma crude protein, and use the concentration process to greatly reduce the drying production cost, using high-pressure spray drying technology to ensure uniformity of the plasma of the poultry plasma products, excellent quality and other indicators .
- the method of the present invention employs ultrafiltration membranes in a specific molecular weight range for ultrafiltration, and ultrafiltration and filtration filtrates are used in subsequent steps, which significantly increases the yield of the final product.
- ultrafiltration membranes such as 0.1 to 300,000 molecular weight can be used for ultrafiltration of chicken plasma and for preparing chicken blood plasma protein powder, it is not indicated that ultrafiltration filtrate or Retentate, and by the inventors' experiments, the final product yield according to the prior art was low.
- the poultry plasma protein prepared by the method of the invention has excellent indexes, and the protein content is as high as 70%.
- the functional component immunoglobulin is 14%, the palatability is good, the amino acid balance, and the ash content is lower than 14.5%; the various indexes of the poultry plasma protein powder of the invention are high in quality, and are at the leading level at home and abroad.
- the avian plasma protein powder prepared by the invention is used in the feeding experiment of adding the poultry plasma protein powder to the weaned pig diet, and the feeding effect of the poultry plasma protein powder is the best in the comparison test of the plasma protein powder added to the weaned pig diet.
- Nutritional metabolism and immunity levels of weaned piglets The invention will be further elucidated below in conjunction with specific implementations. It is to be understood that the examples are merely illustrative of the invention and are not intended to limit the scope of the invention.
- the experimental methods in the following examples which do not specify the specific conditions are usually in accordance with conventional conditions, for example, according to the conditions recommended by the manufacturer. Unless otherwise stated, the percentages and parts are calculated by weight.
- the indicators of the present invention (such as the content of protein (including IgY), ash, moisture, or salt in avian blood plasma protein powder; or the immunoglobulin (IgG) content of raising piglets) and the feeding of piglets
- the calculation method of the weight ratio is a method well known to those skilled in the art.
- the impurities such as hair and stones are removed by filtration through a filter bag, and then centrifuged (11,000 rpm) using a blood tube centrifuge to obtain a light liquid as a plasma solution. .
- the decalcified plasma solution was ultrafiltered using a 400,000 molecular weight filter to remove fibrinogen and most of the oil to obtain filtrate plasma.
- the emulsifier is obtained by adding emulsifier (sorbitol) to the filtrated plasma, and emulsifying the residual oil.
- the amount of the emulsifier is 0.1% (w/w) of the plasma obtained in the previous step. plasma.
- the emulsified plasma is concentrated by 200 molecular weight membrane nanofiltration and concentrated to concentrated plasma: filtered water The volume ratio is 1:3, and most of the water and salt in the plasma are removed to obtain a concentrated plasma solution.
- plasma protein powder 1 At 80-85 ° C, low ash plasma protein powder is obtained, which is plasma protein powder 1
- the preparation method was the same as in Example 1.
- the specific conditions were as described in Table 2.
- the amount of the decalcifying agent added is calculated according to the total weight of the plasma (liquid) obtained in the step (2) of the embodiment (w/w); the amount of the emulsifier added is the plasma obtained in the step (5) of the embodiment ( Liquid) total weight calculation (w/w)
- the protein content of the poultry blood plasma protein powder 2-3 is detected to be as high as 70%, wherein the functional component immunoglobulin is 14%, and the ash content is less than 14.5%.
- Example 5 Preparation of avian blood plasma protein powder 4
- the impurities such as hair and stones are removed by filtration through a filter bag, and then centrifuged (11,000 rpm) using a blood tube centrifuge to obtain a light liquid as a plasma solution. .
- the decalcified plasma solution was ultrafiltered using a 500,000 molecular weight filter to remove fibrinogen and most of the oil to obtain filtrate plasma.
- the amount of the plasma obtained in the previous step is 0.08% ( (0% by weight of the plasma obtained in the previous step). w/w) , obtained emulsified plasma.
- the emulsified plasma is concentrated by nanofiltration of a molecular weight membrane of 200, and concentrated to a concentrated plasma: the volume ratio of the filtered water is 1:3.3, and most of the water and salt in the plasma are removed to obtain a concentrated plasma solution.
- the concentrated plasma solution is spray-dried, the inlet air temperature is controlled at 220-230 ° C, and the outlet air temperature is 80-85 ° C to obtain low-ash avian plasma protein powder, which is plasma protein powder 4 .
- the impurities such as hair and stones are removed by filtration through a filter bag, and then centrifuged (11,000 rpm) using a blood tube centrifuge to obtain a light liquid as a plasma solution. .
- the decalcified plasma solution was ultrafiltered using a 400,000 molecular weight filter to remove fibrinogen and most of the oil to obtain filtrate plasma.
- the emulsified plasma was concentrated by nanofiltration with a molecular weight membrane of 200 and concentrated to a concentrated plasma: the volume ratio of filtered water was 1:3.1, and most of the water and salt in the plasma were removed to obtain a concentrated plasma solution.
- the concentrated plasma solution is spray-dried, the inlet air temperature is controlled at 220-230 ° C, and the outlet air temperature is 80-85 ° C to obtain low-ash avian plasma protein powder, which is plasma protein powder 5 .
- a certain amount of avian blood protein powder was added to the feed, and the effects of the immunoglobulin (IgG) content and the feed-to-weight ratio of the piglets were compared with and without the avian blood protein powder.
- IgG immunoglobulin
- Test group Example 1-5 Low ash avian plasma protein powder prepared according to any one; Adding amount: 0.4% (w/w, calculated by total weight of feed)
- Control group Soy protein concentrate; Addition amount: 0.4% (w/w, based on the total weight of the feed) Piglet age: 28 days weaned piglets
- avian plasma protein powder can significantly increase the immunoglobulin content of piglets.
- the preparation method of the related indexes of avian blood plasma protein powder produced by the molecular weights of different ultrafiltration membranes of Comparative Example 1 and Comparative Example 2 was the same as that of Example 1, except that: The step (5) of Comparative Example 1 is carried out by ultrafiltration using a 200,000 molecular weight ultrafiltration membrane;
- the step (5) of Comparative Example 2 was carried out by ultrafiltration using a 0. 1 million molecular weight ultrafiltration membrane.
- Example 4 The preparation method was the same as in Example 1, except that Comparative Example 4 was not added with a decalcifying agent (i.e., without the step (3) and the step (4) of Example 1).
- Comparative Example 4 was added to the step (6) of Example 1 between the step (5) and the step (7) of Comparative Example 3 as compared with Comparative Example 3:
- the emulsifier is obtained by adding an emulsifier (sorbitol) to the filtrated plasma, and emulsifying the residual oil.
- the amount of the emulsifier is 0.1% (w/w) of the plasma obtained in the previous step. plasma.
- the effects of decalcifying agents and emulsifiers on nanofiltration results and process energy consumption are shown in Table 7.
- Example 1 750 kg of salt water can be removed to produce 250 kg of chicken blood plasma concentrate; in Comparative Example 4, about 703 kg of salt water can be removed to produce about 297 kg of chicken blood plasma concentrate; In 3, 670 kg of salt water can be removed to produce 330 kg of chicken plasma concentrate.
- Example 1 can save 520 yuan / ton of avian blood protein powder
- Example 1 can save 120 yuan / ton of avian blood protein powder.
- the method of the present invention can not only fill the gap in the demand for protein feed in China, but also realize the rational use of waste resources.
- the breakthrough and innovation of the avian blood processing technology of the present invention provides technical guarantee for realizing large-scale development and utilization of avian blood.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/384,010 US9578889B2 (en) | 2012-03-09 | 2013-03-08 | Method for producing low-ash poultry plasma protein powder by utilizing poultry blood |
EP13757800.1A EP2823714B1 (en) | 2012-03-09 | 2013-03-08 | Method for producing low-ash poultry plasma protein powder by utilizing poultry blood |
MX2014010891A MX351742B (es) | 2012-03-09 | 2013-03-08 | Metodo para producir un polvo de proteina de plasma de ave de corral con bajo contenido de ceniza utilizando sangre de ave de corral. |
RU2014140683/10A RU2604190C2 (ru) | 2012-03-09 | 2013-03-08 | Способ получения малозольного порошка белка птичьей плазмы с использованием птичьей крови |
CA2866741A CA2866741C (en) | 2012-03-09 | 2013-03-08 | Method for producing low-ash poultry plasma protein powder by utilizing poultry blood |
ES13757800.1T ES2655213T3 (es) | 2012-03-09 | 2013-03-08 | Método para producir un polvo de proteína de plasma de ave de corral con bajo contenido de ceniza utilizando sangre de ave de corral |
JP2014560238A JP5990286B2 (ja) | 2012-03-09 | 2013-03-08 | 禽類の血液を使用して低灰分禽類血漿タンパク質粉末を生産する方法 |
PL13757800T PL2823714T3 (pl) | 2012-03-09 | 2013-03-08 | Sposób wytwarzania proszku białkowego o niskiej zawartości popiołu z osocza drobiu z użyciem krwi drobiowej |
BR112014022273-8A BR112014022273B1 (pt) | 2012-03-09 | 2013-03-08 | método de preparação para um pó de proteína do plasma de ave doméstica de baixo conteúdo de cinza |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210062535.2A CN102599332B (zh) | 2012-03-09 | 2012-03-09 | 一种利用禽血生产低灰分禽血浆蛋白粉的方法 |
CN201210062535.2 | 2012-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013131494A1 true WO2013131494A1 (zh) | 2013-09-12 |
Family
ID=46517408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/072366 WO2013131494A1 (zh) | 2012-03-09 | 2013-03-08 | 一种利用禽血生产低灰分禽血浆蛋白粉的方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9578889B2 (zh) |
EP (1) | EP2823714B1 (zh) |
JP (1) | JP5990286B2 (zh) |
CN (1) | CN102599332B (zh) |
BR (1) | BR112014022273B1 (zh) |
CA (1) | CA2866741C (zh) |
ES (1) | ES2655213T3 (zh) |
MX (1) | MX351742B (zh) |
PL (1) | PL2823714T3 (zh) |
RU (1) | RU2604190C2 (zh) |
WO (1) | WO2013131494A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102599332B (zh) | 2012-03-09 | 2014-07-30 | 上海杰隆生物制品股份有限公司 | 一种利用禽血生产低灰分禽血浆蛋白粉的方法 |
CN103039693B (zh) * | 2013-01-09 | 2014-04-30 | 合肥工业大学 | 改性畜禽血浆蛋白粉的制备方法 |
CN106922946A (zh) * | 2015-12-31 | 2017-07-07 | 上海杰隆生物制品股份有限公司 | 一种包含油脂的动物血浆蛋白粉的制备方法 |
EP3411383A4 (en) | 2016-02-03 | 2019-08-14 | Plasma Technologies, LLC | METHODS FOR EXTRACTING PROTEINS FROM BLOOD MATERIAL |
CN105941820A (zh) * | 2016-05-05 | 2016-09-21 | 青海大学 | 一种藏羊血浆蛋白粉的生产方法 |
CN106749625A (zh) * | 2016-12-20 | 2017-05-31 | 中国农业科学院农产品加工研究所 | 血浆蛋白和血红蛋白联产装置 |
PL231961B1 (pl) * | 2016-12-21 | 2019-04-30 | Pobudkiewicz Bartlomiej Krzysztof | Sposób wytwarzania suszonych rozpyłowo produktów krwi drobiowej |
PT3459356T (pt) | 2018-01-22 | 2020-09-11 | Tessenderlo Group Nv | Método melhorado para produzir farinha de sangue |
KR102186526B1 (ko) * | 2019-01-11 | 2020-12-03 | 주식회사 에스씨아이 | 도축 혈액을 이용한 면역 증강용 사료첨가제의 제조방법, 이에 따라 제조된 사료 첨가제 및 이를 포함하는 가축용 사료 |
US10815270B1 (en) | 2019-09-20 | 2020-10-27 | Plasma Technologies, Llc | Compositions and methods for high efficiency protein precipitation |
CN111172108A (zh) * | 2019-11-26 | 2020-05-19 | 青岛大学 | 一种组织液的制备方法 |
CN111871625A (zh) * | 2020-07-15 | 2020-11-03 | 江苏永盛生物科技有限公司 | 一种低灰分的猪血浆蛋白粉的制备工艺及其装置 |
CN111956789A (zh) * | 2020-07-20 | 2020-11-20 | 北京西峰科技有限责任公司 | 一种适用于血液净化患者的营养物的制备方法及营养物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849612A (zh) * | 2009-04-03 | 2010-10-06 | 鹤壁普乐泰生物科技有限公司 | 一种鸡血血浆蛋白粉的制备工艺 |
CN102210372A (zh) * | 2011-03-30 | 2011-10-12 | 景志刚 | 从动物血中提取高纯短肽蛋白粉的方法 |
CN102318722A (zh) * | 2011-06-15 | 2012-01-18 | 天津宝迪农业科技股份有限公司 | 一种高蛋白食品级血浆蛋白粉的制备方法 |
CN102599332A (zh) * | 2012-03-09 | 2012-07-25 | 上海杰隆生物制品股份有限公司 | 一种利用禽血生产低灰分禽血浆蛋白粉的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE440596B (sv) * | 1980-04-03 | 1985-08-12 | Paul Goran Sigvard Lindroos | Forfarande for framstellning av ett heme-koncentrat ur en blandning av heme och blodsubstans erhallen vid spaltning av hemoglobin |
IT1135153B (it) * | 1981-01-23 | 1986-08-20 | Consiglio Nazionale Ricerche | Processo per rendere incoagulabile il sangue mediante enzimi proteolitici e uso del sangue incoagulabile per produrre un concentrato proteico da sangue intero |
JPH03240443A (ja) * | 1990-02-16 | 1991-10-25 | Shokuhin Sangyo Haisepareeshiyon Syst Gijutsu Kenkyu Kumiai | 無異臭プラズマ製品の製造法 |
JPH0416167A (ja) * | 1990-05-02 | 1992-01-21 | Taiyo Kagaku Co Ltd | ハム・ソーセージの製造法 |
US6663780B2 (en) * | 1993-01-26 | 2003-12-16 | Danisco Finland Oy | Method for the fractionation of molasses |
RU2096965C1 (ru) * | 1995-04-11 | 1997-11-27 | Всероссийский научно-исследовательский институт мясной промышленности | Способ получения белкового гидролизата из крови |
EP0818152B2 (en) * | 1996-05-15 | 2008-11-19 | Veos N.V. | Processed globin products and methods for the production thereof |
US6096872A (en) * | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
CN1127299C (zh) * | 2000-03-30 | 2003-11-12 | 上海杰隆生物工程股份有限公司 | 一种动物全血加工方法 |
RU2274003C2 (ru) * | 2004-03-02 | 2006-04-20 | Станислав Людвигович Люблинский | Способ комплексной переработки крови сельскохозяйственных животных для получения биологически активного вещества с противоанемическими свойствами на основе гемоглобина, биологически активное вещество с противоанемическими свойствами (варианты) и продукт, его содержащий (варианты). |
CN101124938B (zh) * | 2006-08-17 | 2012-07-04 | 上海杰隆生物制品股份有限公司 | 利用高压均质技术处理动物血液分离出的新鲜血浆及新鲜血球 |
CN102010459B (zh) * | 2010-09-10 | 2012-08-29 | 合肥工业大学 | 一种畜禽血浆蛋白粉的制备方法 |
CN102132760B (zh) * | 2010-10-29 | 2013-01-09 | 成都天屹生物科技有限公司 | 一种低灰分的猪血浆蛋白粉的制备方法 |
-
2012
- 2012-03-09 CN CN201210062535.2A patent/CN102599332B/zh active Active
-
2013
- 2013-03-08 JP JP2014560238A patent/JP5990286B2/ja not_active Expired - Fee Related
- 2013-03-08 CA CA2866741A patent/CA2866741C/en not_active Expired - Fee Related
- 2013-03-08 ES ES13757800.1T patent/ES2655213T3/es active Active
- 2013-03-08 US US14/384,010 patent/US9578889B2/en active Active
- 2013-03-08 WO PCT/CN2013/072366 patent/WO2013131494A1/zh active Application Filing
- 2013-03-08 BR BR112014022273-8A patent/BR112014022273B1/pt not_active IP Right Cessation
- 2013-03-08 PL PL13757800T patent/PL2823714T3/pl unknown
- 2013-03-08 RU RU2014140683/10A patent/RU2604190C2/ru active
- 2013-03-08 MX MX2014010891A patent/MX351742B/es active IP Right Grant
- 2013-03-08 EP EP13757800.1A patent/EP2823714B1/en not_active Not-in-force
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849612A (zh) * | 2009-04-03 | 2010-10-06 | 鹤壁普乐泰生物科技有限公司 | 一种鸡血血浆蛋白粉的制备工艺 |
CN102210372A (zh) * | 2011-03-30 | 2011-10-12 | 景志刚 | 从动物血中提取高纯短肽蛋白粉的方法 |
CN102318722A (zh) * | 2011-06-15 | 2012-01-18 | 天津宝迪农业科技股份有限公司 | 一种高蛋白食品级血浆蛋白粉的制备方法 |
CN102599332A (zh) * | 2012-03-09 | 2012-07-25 | 上海杰隆生物制品股份有限公司 | 一种利用禽血生产低灰分禽血浆蛋白粉的方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2866741A1 (en) | 2013-09-12 |
US20150056363A1 (en) | 2015-02-26 |
JP5990286B2 (ja) | 2016-09-07 |
MX351742B (es) | 2017-10-26 |
JP2015511485A (ja) | 2015-04-20 |
BR112014022273B1 (pt) | 2020-06-30 |
PL2823714T3 (pl) | 2018-06-29 |
CA2866741C (en) | 2018-02-06 |
RU2014140683A (ru) | 2016-04-27 |
RU2604190C2 (ru) | 2016-12-10 |
EP2823714A1 (en) | 2015-01-14 |
ES2655213T3 (es) | 2018-02-19 |
US9578889B2 (en) | 2017-02-28 |
MX2014010891A (es) | 2015-05-08 |
EP2823714A4 (en) | 2015-12-09 |
CN102599332A (zh) | 2012-07-25 |
CN102599332B (zh) | 2014-07-30 |
EP2823714B1 (en) | 2017-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013131494A1 (zh) | 一种利用禽血生产低灰分禽血浆蛋白粉的方法 | |
CN103205480B (zh) | 一种用鱼皮或鱼骨生产胶原蛋白低聚肽的方法 | |
JP4680989B2 (ja) | タンパク質単離処理におけるフィチン酸の低減 | |
JP6666851B2 (ja) | 濃縮タンパク質組成物ならびにその製造および使用方法 | |
JP6882894B2 (ja) | 小粒径のタンパク質組成物および製造方法 | |
JP2015511485A5 (zh) | ||
JP7011060B2 (ja) | ジャガイモタンパク質由来繊維状構造及びそれを含む食料品 | |
JP6723224B2 (ja) | 大豆タンパク質生成物(「s810」)の調製 | |
CN106035980B (zh) | 一种利用酶解法肝素吸附残液生产肠膜蛋白粉的方法 | |
JP4921464B2 (ja) | コレステロール除去用β−シクロデキストリンの架橋化及びその再生方法 | |
JPH08501688A (ja) | ベータ・カゼイン強化製品の製造方法 | |
US8642038B2 (en) | Isolated egg protein and egg lipid materials, and methods for producing the same | |
CN102286592B (zh) | 一种猪肺蛋白肽的制备方法 | |
CN103030645A (zh) | 一种大规模制备高纯度血红素的方法及应用 | |
WO2010005830A1 (en) | Low fat, clear, bland flavored, whey products | |
MX2012014358A (es) | Materiales aislados de proteinas de huevo y lipidos de huevo y metodos para producir los mismos. | |
RU2287959C2 (ru) | Способ производства натуральных структурообразователей из рыбных отходов | |
CN110623243B (zh) | 高钙盐类复合物及其制备方法 | |
CN102265961A (zh) | 一种动物血浆蛋白粉脱色脱腥的方法 | |
KR100244792B1 (ko) | 가축혈액으로부터이취및색택을개선한식품첨가용면역단백질의회수방법 | |
RU2481772C2 (ru) | Способ получения белкового концентрата из рыбных отходов | |
RU2658844C1 (ru) | Способ получения кормовой добавки из морских звезд | |
CN116982656A (zh) | 一种对乳及乳制品中各组分进行分离的方法和装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13757800 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2866741 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2014560238 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14384010 Country of ref document: US Ref document number: MX/A/2014/010891 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2014140683 Country of ref document: RU Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2013757800 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013757800 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014022273 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014022273 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140909 |